Heart Failure NYHA Class III Clinical Trial
— CHATTOfficial title:
We Chatt (Communication, Hopes, Action, Tips and Team) A Study to Improve Physician-Youth Communication and Medical Decision Making
Verified date | June 2024 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is improving patient-centered communication for young people with advanced heart disease.
Status | Completed |
Enrollment | 62 |
Est. completion date | June 7, 2024 |
Est. primary completion date | June 7, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years and older |
Eligibility | Physician Inclusion Criteria: - Physician participants will be recruited from the Division of Pediatric Cardiology at the University of Michigan. All physicians with dedicated clinical effort will be eligible. - Eligible physicians must anticipate remaining on staff >1 year Patient/Caregiver Inclusion Criteria: - Patients 12-24 years old with heart failure symptoms meeting criteria for New York Heart Association (NYHA) Class II - IV heart failure - One parent/caregiver of patient participants meeting inclusion criteria will also be eligible Physician Exclusion Criteria: - Not a physician at University of Michigan in the Division of Pediatric Cardiology Patient/Caregiver Exclusion Criteria: - Patients with significant cognitive/developmental delay with potential to impact study participation will be excluded from the study due to the focus on physician-youth communication. - Parents and parent/caregivers that are non-English speaking will be excluded from this pilot study. |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physician overall satisfaction with the We Chatt intervention based on the post clinician survey | Satisfaction will be based on the answers for 12 questions in which clinician's select from a likert scale from strongly disagree (1) -Strongly agree (5). The scores ranging from 12-60; higher scores indicate greater satisfaction. | 2 weeks (after intervention) | |
Primary | Patient/Caregiver overall satisfaction with the We Chatt intervention based on the parent/caregiver survey | Parent/Caregiver will complete 12 questions in which participants select from a likert scale from Strongly disagree (1) -Strongly agree (5). The scores ranging from 12-60; higher scores indicate greater satisfaction. | 2 weeks (after intervention) | |
Primary | Patient overall satisfaction with the We Chatt intervention based on the patient survey | Patients will complete 12 questions in which participants select from a likert scale from Strongly disagree (1) -Strongly agree (5). The scores ranging from 12-60; higher scores indicate greater satisfaction. | 2 weeks (after intervention) | |
Secondary | Physician satisfaction with the We Chatt intervention from physicians based on the post clinician survey | Physicians will answer 1 question on a scale from 0-10 (with 0 being worst and 10 being best) | 2 weeks (after intervention) | |
Secondary | Parent/Caregiver satisfaction with the We Chatt intervention based on the parent/caregiver survey | Parent/Caregiver will answer 1 question on a scale from 0-10 (with 0 being worst and 10 being best) | 2 weeks (after intervention) | |
Secondary | Patient satisfaction with the We Chatt intervention based on the patient survey | Patients will answer 1 question on a scale from 0-10 (with 0 being worst and 10 being best) | 2 weeks (after intervention) | |
Secondary | Time (measured in minutes) to complete We Chatt the Intervention by clinicians | Number of minutes to complete the intervention will be collected on clinician survey. | 30 minutes (approximately) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04452149 -
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
|
N/A | |
Not yet recruiting |
NCT06097481 -
Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03005184 -
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
|
Phase 2 | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT03895073 -
HEart fAiluRe evaluaTion Questionnaire
|
||
Completed |
NCT03095196 -
Multipolar CRT-d and Diabetes
|
N/A | |
Recruiting |
NCT03180320 -
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
|
N/A | |
Completed |
NCT06233695 -
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
|
||
Withdrawn |
NCT03947853 -
Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
|
||
Recruiting |
NCT05934487 -
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
|
N/A | |
Recruiting |
NCT04829617 -
Promoting Well-being and Health in Heart Failure
|
N/A | |
Recruiting |
NCT03538990 -
Effect of DASH Eating Pattern on Heart Failure Outcomes
|
N/A | |
Recruiting |
NCT05487365 -
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF
|
N/A | |
Completed |
NCT03592836 -
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
|
Phase 3 | |
Completed |
NCT01560871 -
Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
|
N/A | |
Completed |
NCT03387813 -
Hemodynamic-GUIDEd Management of Heart Failure
|
N/A | |
Not yet recruiting |
NCT06270875 -
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
|
N/A | |
Enrolling by invitation |
NCT05885607 -
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
|
||
Active, not recruiting |
NCT04012944 -
SIRONA 2 Trial Heart Failure NYHA Class III
|
N/A | |
Recruiting |
NCT05879887 -
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
|
N/A |